Gastrointestinal Endoscopy Devices | Market Insights | US | 2022
The COVID-19 pandemic has an impact not only on the screening and elective interventional procedures but also on the overall healthcare system in the US. There is a limited negative impact on the US GI endoscopy device market and once the market recovers, it will expand moderately through 2030. New treatment and screening guidelines, as well as the introduction of less invasive screening and therapeutic technologies, will support procedure volumes across the US. The introduction of innovative products to meet current treatment protocols and curb the spread of infections will keep the market buoying. However, an accelerated hospital consolidation, reimbursement changes, and the ongoing shift toward value-based care in the US will limit market expansion to some degree.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for GI endoscopy devices in the US across an 11-year period.
